Center for Immunotherapy and Cell-Based Technologies
Novosibirsk — Kaliningrad — Moscow — Irkutsk
Main →
Lung cancer
Xenovaccinotherapy for cancer
http://www.medicalnewstoday.com/rss/cancer-oncology.xmlhttp://www.medicalnewstoday.com/rss/immune_system.xmlhttp://www.medicalnewstoday.com/rss/multiple_sclerosis.xmlhttp://www.medicalnewstoday.com/rss/stem_cell_research.xml
22.02.2012
Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to...
18.02.2012
Drugs targeting an enzyme involved in inflammation might offer a new avenue for treating certain lung cancers, according to a new study by scientists ...
13.02.2012
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two role...
24.01.2012
According to a study published January 23 online in Cancer, many smokers do not drop the habit after being diagnosed with colorectal or lung cancer. ...
08.01.2012
Over the last twenty years, more than one million deaths from cancer have been avoided, researchers reported in CA: A Cancer Journal for Clinicians. D...
06.01.2012
Data assessing custirsen (OGX-011/TV-1011), an investigational compound, in individuals with advanced non-small cell lung cancer (NSCLC) were publishe...
04.01.2012
Each year in the U.S., lung cancer kills more individuals than prostate, colon, and breast cancers combined. Often the disease goes undetected until i...
25.12.2011
It has been well established that certain lifestyle habits relate to the risk of certain cancers (e.g., smoking and lung cancer). In a well-done analy...
21.12.2011
A Wayne State University researcher has shown that compounds found in soybeans can make radiation treatment of lung cancer tumors more effective whil...
12.12.2011
Bowel cancer is responsible for 16,000 deaths annually in the UK alone. Bowel cancer is the second leading cause of death in the UK and Europe after ...
Immunotherapy for cancer
An active specific immunotherapy (vaccinotherapy) is a strategy using tumor-associated antigens for including antitumor immune responses. The small structural distinctions of the xenogenic tumor-associated antigens from their human analogues render these antigens highly immunogenic and capable of including immune-mediated, antitumor responses in a patient not only at early, but also at advanced stages of disease, when tumor-derived immunosuppression is significant. Tumor-specfic immunotherapy is able to generate a selective and long-term antitumor effect. Such a therapy has no complications attributable to chemotherapy.
Xenovaccinotherapy for cancer
